| 12473314 |
Phospholipid compounds and uses thereof |
Scott E. Lazerwith, Jonathan William Medley, Philip Anthony Morganelli, Thomas P. Stratton, Peiyun Wang |
2025-11-18 |
|
| 12410183 |
Sars-cov2 main protease inhibitors |
Stephen E. Ammann, Xinpei Cai, Eda Canales, Weng K. Chang, Gregory Chin +9 more |
2025-09-09 |
|
| 12338233 |
PD-1/Pd-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2025-06-24 |
|
| 12269812 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Michael Graupe, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello +9 more |
2025-04-08 |
|
| 12202842 |
MCL1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Lan Jiang, Darryl Kato +8 more |
2025-01-21 |
|
| 12187734 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2025-01-07 |
|
| 12162844 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2024-12-10 |
$252,679,000 |
| 12116380 |
Phospholipid compounds and methods of making and using the same |
Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Deeba Ensan, Rao V. Kalla, Richard L. Mackman +2 more |
2024-10-15 |
$702,640,000 |
| 12110305 |
Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use |
Daniel H. Byun, Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Petr Jansa, Neil H. Squires |
2024-10-08 |
$323,137,000 |
| 12091420 |
SARS-COV2 main protease inhibitors |
Stephen E. Ammann, Xinpei Cai, Eda Canales, Weng K. Chang, Gregory Chin +8 more |
2024-09-17 |
$320,643,000 |
| 12030904 |
Phospholipid compounds and uses thereof |
Scott E. Lazerwith, Jonathan William Medley, Philip Anthony Morganelli, Thomas P. Stratton, Peiyuan Wang |
2024-07-09 |
$175,383,000 |
| 11897892 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2024-02-13 |
$118,355,000 |
| 11773122 |
Phospholipid compounds and uses thereof |
Scott E. Lazerwith, Jonathan William Medley, Philip Anthony Morganelli, Thomas P. Stratton, Peiyuan Wang |
2023-10-03 |
$270,496,000 |
| 11718637 |
Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same |
Daniel H. Byun, Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Petr Jansa, Richard L. Mackman +1 more |
2023-08-08 |
$593,843,000 |
| 11667652 |
MCL1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Lan Jiang, Darryl Kato +8 more |
2023-06-06 |
$568,374,000 |
| 11643400 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2023-05-09 |
$305,124,000 |
| 11613546 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2023-03-28 |
$310,764,000 |
| 11555029 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2023-01-17 |
$669,972,000 |
| 11021467 |
Phosphatidylinositol 3-kinase inhibitors |
Shaopei Cai, Zhimin Du, Musong Kim, Jennifer A. Loyer-Drew, Leena Patel +7 more |
2021-06-01 |
$494,660,000 |
| 10988451 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2021-04-27 |
$236,030,000 |
| 10899735 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2021-01-26 |
$775,784,000 |
| 10774071 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Michael Graupe, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello +9 more |
2020-09-15 |
$253,208,000 |
| 10710986 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2020-07-14 |
$847,542,000 |
| 10703733 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2020-07-07 |
$851,015,000 |
| 10479770 |
Phosphatidylinositol 3-kinase inhibitors |
Jayaraman Chandrasekhar, Leena Patel, Stephane Perreault, Gary Phillips, Kassandra F. Sedillo +5 more |
2019-11-19 |
$392,391,000 |